Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Disease Models & Mechanisms
|
September 24, 2015
A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations
Michael Buchert, Franziska Rohde, Moritz Eissmann, et al.
Gastroenterology
|
October 9, 2007
Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors
Julie Pannequin, Nathalie Delaunay, Michael Buchert, et al.
The Journal of Clinical Investigation
|
January 17, 2013
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice
Stefan Thiem, Thomas P Pierce, Michelle Palmieri, et al.
The Journal of Clinical Investigation
|
April 24, 2008
STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
Matthias Ernst, Meri Najdovska, Dianne Grail, et al.
Molecular Cancer Therapeutics
|
February 10, 2021
Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK
David K Lau, Ian Y Luk, Laura J Jenkins, et al.
Nature Communications
|
June 23, 2019
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
Moritz F Eissmann, Christine Dijkstra, Andrew Jarnicki, et al.
The Biochemical Journal
|
February 3, 2005
Distinct requirements for the Sprouty domain for functional activity of Spred proteins
James A J King, Andrew F L Straffon, Giovanna M D'Abaco, et al.
Development (Cambridge, England)
|
June 28, 2021
EHF is essential for epidermal and colonic epithelial homeostasis, and suppresses Apc-initiated colonic tumorigenesis
Camilla M Reehorst, Rebecca Nightingale, Ian Y Luk, et al.
Science Signaling
|
September 17, 2024
DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression
Shoukat Afshar-Sterle, Annalisa L E Carli, Ryan O'Keefe, et al.
EMBO Reports
|
July 7, 2025
Inhibition of the minor spliceosome restricts the growth of a broad spectrum of cancers
Karen Doggett, Kimberly J Morgan, Anouk M Olthof, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Disease Models & Mechanisms
|
September 24, 2015
A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations
Michael Buchert, Franziska Rohde, Moritz Eissmann, et al.
Gastroenterology
|
October 9, 2007
Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors
Julie Pannequin, Nathalie Delaunay, Michael Buchert, et al.
The Journal of Clinical Investigation
|
January 17, 2013
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice
Stefan Thiem, Thomas P Pierce, Michelle Palmieri, et al.
The Journal of Clinical Investigation
|
April 24, 2008
STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
Matthias Ernst, Meri Najdovska, Dianne Grail, et al.
Molecular Cancer Therapeutics
|
February 10, 2021
Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK
David K Lau, Ian Y Luk, Laura J Jenkins, et al.
Nature Communications
|
June 23, 2019
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
Moritz F Eissmann, Christine Dijkstra, Andrew Jarnicki, et al.
The Biochemical Journal
|
February 3, 2005
Distinct requirements for the Sprouty domain for functional activity of Spred proteins
James A J King, Andrew F L Straffon, Giovanna M D'Abaco, et al.
Development (Cambridge, England)
|
June 28, 2021
EHF is essential for epidermal and colonic epithelial homeostasis, and suppresses Apc-initiated colonic tumorigenesis
Camilla M Reehorst, Rebecca Nightingale, Ian Y Luk, et al.
Science Signaling
|
September 17, 2024
DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression
Shoukat Afshar-Sterle, Annalisa L E Carli, Ryan O'Keefe, et al.
EMBO Reports
|
July 7, 2025
Inhibition of the minor spliceosome restricts the growth of a broad spectrum of cancers
Karen Doggett, Kimberly J Morgan, Anouk M Olthof, et al.
Page
of 5